慢性肺心病合并心力衰竭112例临床分析

Chronic heart disease from lung disorders merge heart failure 112 example clinical analyses

目的：总结治疗慢性肺心痛心力衰竭的临床经验。方法：将112例患者随机分为对照组与治疗组，对照组给予改善通气功能后氧疗以纠正低氧血症和高碳酸血症、抗感染、解痉平喘、强心、利尿、纠正水电质平衡及处理并存疾病等常规治疗。治疗组在常规治疗的基础上，增加酚妥拉明10～20毫克、多巴酚丁胺40毫克加入5％葡萄糖液250毫升内静脉滴注，滴速15滴／min．每日1次，10天为一疗程。结果：治疗组总有效率96．14％。对照组总有效率62．49％．二组比较差异有显著意义（P〈0．05）。结论：多巴酚丁胺、酚妥拉明联用治疗可显著降低心脏前后负荷、改善通气功能，对慢性肺心病合并心力衰竭的疗效显著。

Objective Summary of the treatment of chronic pulmonary heart disease heart failure clinical experience. Methods 112 cases of patients will be randomly divided into control group and treatment group and control group were given oxygen therapy to improve the ventilation feature to correct hypoxemia and hypercapnia, anti-inflammatory, antispasmodic antiasthmatic, cardiotonic, diuretic, to correct water electric balance and quality of treatment of diseases, such as the coexistence of conventional therapy. Treatment group in the conventional treatment, based on the increase in phentolamine 10-20 mg, 40 mg Dobutamine in 5% glucose solution with 250 ml intravenous drip, 15 drops/min, day 1, l0 days for one course of treatment. Results The total efficiency of the treatment group has 96. 14% in the control group the total effective rate 62.49%, difference between the two groups was significant （P〈 0.05）. Conclusions： Dobutamine and phentolamine in the treatment can significantly reduce the heart before and after the load, to improve the ventilation function of chronic pulmonary heart disease with heart failure efficacy significantly.